ZT-003

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameZT-003
Drug Alias NameZT003ZT-003
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFibroblast growth factor 21 agonistsGlucagon-like peptide 1 receptor agonists
TargetsFibroblast growth factor 21Glucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing QL Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing QL Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A